| Name | Cap-dependent endonuclease-IN-1 |
|---|
| Description | Cap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. Patent WO2019144089A1. [2]. Chi-Feng Yen, et al. Amorphous solid dispersion formulation. Patent US20220202817A1. |
| Molecular Formula | C27H22F2N2O6S |
|---|---|
| Molecular Weight | 540.54 |